Evidence map›Paper›PMID 42395784›Full record

ArticleRSC advances2026

Synergistic surface modification of zirconia nanotubes with silver and hydroxyapatite for enhanced early-stage cytocompatibility: ToF-SIMS insights into fibronectin adsorption.

Gabriel Onyenso, Lu Yuan, Nastaran Farahbakhsh, Setareh Orangpour, Paola Carolina Zamudio Franco, Johannes Schmitt, Carsten Engelhard, Christian Pritzel, Henny C van der Mei, Manuela S Killian

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriel OnyensoChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.ORCID https://orcid.org/0009-0003-5140-0055
Lu YuanUniversity of Groningen, University Medical Center of Groningen, Department of Biomaterials & Biomedical Technology Antonius Deusinglaan 1 9713 AV Groningen The Netherlands.
Nastaran FarahbakhshChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.ORCID https://orcid.org/0000-0002-0136-7416
Setareh OrangpourChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.ORCID https://orcid.org/0009-0002-2341-7434
Paola Carolina Zamudio FrancoChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.ORCID https://orcid.org/0009-0004-7041-7255
Johannes SchmittFederal Institute for Materials Research and Testing (BAM) Richard-Willstätter Str. 11 D-12489 Berlin Germany.ORCID https://orcid.org/0000-0001-9470-5631
Carsten EngelhardFederal Institute for Materials Research and Testing (BAM) Richard-Willstätter Str. 11 D-12489 Berlin Germany.
Christian PritzelChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.
Henny C van der MeiUniversity of Groningen, University Medical Center of Groningen, Department of Biomaterials & Biomedical Technology Antonius Deusinglaan 1 9713 AV Groningen The Netherlands.
Manuela S KillianChemistry and Structure of Novel Materials, Department of Chemistry & Biology, University of Siegen Paul-Bonatz-Str. 9-11 57076 Siegen Germany Manuela.Killian@uni-siegen.de.ORCID https://orcid.org/0000-0003-0892-4614

Funding

Surface Analysis Facility for Biomedical ProblemsP41EB002027 · NIBIB · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2003 to 2019
$17.6M
NIBIB NIH HHS P41 EB002027
6 · The paper itself

Abstract

Implant surfaces with multifunctional capabilities that can simultaneously facilitate host cell adhesion and proliferation while minimizing bacterial attachment are essential for the long-term success of an implant. In this study, we present a strategy to improve the early-stage cytocompatibility of silver-modified zirconia nanotubes, a key step to optimizing the surface of zirconia nanotubes to achieve potential dual functionality, by co-modification with silver and hydroxyapatite (Hap) nanoparticles. A novel and straightforward strategy to partially coat zirconia nanotubes (ZrNT) with Hap nanoparticles in a manner that still preserves an accessible nanotubular morphology was introduced. The surface morphology and chemical composition were characterized using SEM, XPS, and ToF-SIMS combined with principal component analysis. Protein adsorption studies reveal that coating with Hap enhances fibronectin adsorption, and the detection of RGD-related fragments

Identifiers

PMID42395784
PMCPMC13325329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.